Skystar Bio Pharmaceutical Co. (SKBI) Reports Q2 Earnings of $0.21; Guides FY11 Revs
Tweet
Share
E-mailGet Alerts SKBI Hot Sheet
Price: $0.00 --0%
Financial Fact:
PROVISION FOR INCOME TAXES: 712.93K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
PROVISION FOR INCOME TAXES: 712.93K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Skystar Bio Pharmaceutical Co. (NASDAQ: SKBI) reported Q2 EPS of $0.21, versus $0.33 reported last year. Revenue for the quarter came in at $9.1 million, versus $8.26 million reported last year.
Sees FY2011 revenue of $52 to $55 million.
Sees FY2011 revenue of $52 to $55 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
- Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
